The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis
- PMID: 29221211
- PMCID: PMC5707105
- DOI: 10.18632/oncotarget.19180
The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis
Abstract
The prevalence of PCOS was investigated in many studies in different continents. However, there is no established prevalence of PCOS for distinct ethnic groups. In the current analysis, we conducted searches in PubMed, The Cochrane Library, EMBASE, CINAHL up to Jan. 2017 to identify studies reporting prevalence of PCOS in the general female population. Forty-two studies were identified, with 13 eligible for evidence synthesis. The prevalence among different ethnicity was estimated using random effect modelling. Our results suggested the lowest prevalence in Chinese women(2003 Rotterdam criterion: 5.6% 95% interval: 4.4-7.3%), and then in an ascending order for Caucasians (1990 NIH criterion: 5.5% 95% interval: 4.8-6.3%), Middle Eastern (1990 NIH 6.1% 95% interval: 5.3-7.1%; 2003 Rotterdam 16.0% 95% interval: 13.8-18.6%; 2006 AES 12.6% 95% interval: 11.3-14.2%), and Black women (1990 NIH: 6.1% 95% interval: 5.3-7.1%).There is variation in prevalence of PCOS under different diagnostic criteria and across ethnic groups. This emphasises the need for ethnicity-specific guidelines for PCOS to prevent under- or over-diagnosis of the condition given that under-diagnosis may lead to rapid conversion of metabolic disorders for patients whereas over-diagnosis may exert negative psychological effects on patients which worsens the major symptoms of PCOS.
Keywords: ethnicity; polycystic ovary syndrome; prevalence; systematic review.
Conflict of interest statement
CONFLICTS OF INTEREST None declared.
Figures
Similar articles
-
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16. Hum Reprod. 2014. PMID: 24435776
-
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.Hum Reprod. 2012 Oct;27(10):3067-73. doi: 10.1093/humrep/des232. Epub 2012 Jul 9. Hum Reprod. 2012. PMID: 22777527
-
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12. Hum Reprod. 2010. PMID: 19910321
-
The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis.Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2747-2753. doi: 10.1016/j.dsx.2019.06.008. Epub 2019 Jun 8. Diabetes Metab Syndr. 2019. PMID: 31405703
-
Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity.Reprod Med Biol. 2025 Jan 22;24(1):e12630. doi: 10.1002/rmb2.12630. eCollection 2025 Jan-Dec. Reprod Med Biol. 2025. PMID: 39845478 Free PMC article. Review.
Cited by
-
Chronic inflammation in polycystic ovary syndrome: A case-control study using multiple markers.Int J Reprod Biomed. 2021 Apr 22;19(4):313-320. doi: 10.18502/ijrm.v19i4.9057. eCollection 2021 Apr. Int J Reprod Biomed. 2021. PMID: 33997590 Free PMC article.
-
Polycystic ovary syndrome is linked with the fat mass obesity (FTO) gene variants rs17817449 and rs1421085 in western Saudi Arabia.Bioinformation. 2021 Nov 30;17(11):904-910. doi: 10.6026/97320630017904. eCollection 2021. Bioinformation. 2021. PMID: 35655906 Free PMC article.
-
Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model.Evol Med Public Health. 2021 Sep 17;9(1):295-310. doi: 10.1093/emph/eoab029. eCollection 2021. Evol Med Public Health. 2021. PMID: 34659773 Free PMC article. Review.
-
Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome.Saudi Pharm J. 2023 Jun;31(6):1104-1108. doi: 10.1016/j.jsps.2023.03.021. Epub 2023 Apr 5. Saudi Pharm J. 2023. PMID: 37293383 Free PMC article.
-
Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.J Endocr Soc. 2017 Nov 2;1(12):1417-1427. doi: 10.1210/js.2017-00323. eCollection 2017 Dec 1. J Endocr Soc. 2017. PMID: 29264465 Free PMC article.
References
-
- Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685–697. - PubMed
-
- Livadas S, Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm Res. 2013;40:1–21. - PubMed
-
- Zhao H, Lv Y, Li L, Chen ZJ. Genetic Studies on Polycystic Ovary Syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology. 2016;37:56–65. - PubMed
-
- Jones MR, Goodarzi MO. Genetic determinants of polycystic ovary syndrome: progress and future directions. Fertility and sterility. 2016;106:25–32. - PubMed
-
- Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic Ovary Syndrome. 1992. pp. 377–384.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical